Hello to the board You know that this story has not been sold to retailers when the same people have been on the board for years!
Let's see if we will have new people to talk to soon!
Huge insider holdings on this play, I would imagine with Data pending on a new mechanism of action for a multi billion dollar industry that no one will be selling.
It is crazy that these guys last raised at $1.50 and after an international plasebo controlled phase 2 has they are sitting at 1.26 waiting for results.
I guess if Data isn't good there won't be as much downside, but if it's good than too the moon!
the best part is that Turkey looked at the safety of this drug before expanding participants, so that's half the battle.